AI algorithms can accurately identify tricuspid regurgitation in echocardiograms, supporting timely diagnosis and ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the patient's heart.

In line with its 'Patient First' commitment, and as part of the "Nabadat" campaign, a humanitarian initiative aimed at ...

Holston Valley Medical Center is the first hospital in East Tennessee, Southwest Virginia and Southeast Kentucky to offer ...

Edwards SAPIEN M3 mitral valve replacement system receives CE Mark for transcatheter treatment: Irvine, California Wednesday, ...

Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.

A retrospective analysis from Israel suggested that markers of poor hydration are linked to increased risks of hypertension ...

At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available medical therapy plus a minimally invasive procedure using a clip to ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

Edwards’ device, dubbed Sapien M3, is the first approved system to use a transfemoral approach to treating mitral ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received ...

A rare case of cor triatriatum was diagnosed in a 34-year-old woman using transoesophageal echocardiography after initial ...